Supplementary Figure 7 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 7 - PDF file 126K, Representative images of clonogenic assay with MDA-MB-231 cells</p

Supplementary Figure 3 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 3 - PDF file 83K, Trypan blue dye exclusion analysis of MDA-MB-231, BT-20 and MDA-MB-468 cells treated with dexamethasone +/-mifepristone and paclitaxel</p

Supplementary Methods 1 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Methods 1 - PDF file 64K, Annotated ImageJ macro for quantifying total cell numbers and apoptotic cells using digitally captured IncuCyte images</p

Supplementary Figure 5 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 5 - PDF file 165K, alphaGR and DAPI analysis of MDA-MB-231 xenografts</p

Supplementary Figure 2 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 2 - PDF file 168K, Phase-contrast and fluorescent images of apoptotic MDA-MB-231 cells</p

Supplementary Figure 6 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 6 - PDF file 1359K, Western analysis of GR isoforms from MDA-MB-231 xenografts</p

Supplementary Figure Legends from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure Legends - PDF file 104K, Supplemental figure legends 1-7</p

Supplementary Methods 2 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Methods 2 - PDF 64K, Annotated ImageJ macro for measuring GR+ and total cell counts in MDA-MB-231 xenografted mammary gland tumors</p

Supplementary Figure 1 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 1 - PDF file 129K, In vitro analysis of MDA-MB-231, BT-20, and MDA-MB-468 total live cell counts following treatment</p

Supplementary Figure 4 from Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer

Supplementary Figure 4 - PDF file 1452K, Caspase-2 cleavage following treatment with mifepristone</p